On May 10, 2008, NYUCD hosted and cosponsored a regional conference entitled End the Pain, which focused on patients who suffer from chronic facial pain. More than 260 patients and healthcare professionals attended.
A panel of outstanding clinicians and scientists, including neurologists, neurosurgeons, and an orofacial pain specialist, presented the latest findings on chronic facial pain. Topics included: Defining Neuropathic Face Pains; History of Trigeminal Neuralgia; Medical and Dental Treatment of Chronic Facial Pain; An Overview of Surgical Procedures; Microvascular Decompression; Percutaneous Procedures; Radiosurgery Principles and CyberKnife; Gamma Knife; Stimulation Therapies; and Botox: Controversy & Opportunity.
The conference was organized by the Trigeminal Neuralgia Association and Dr. David A. Sirois, Associate Professor of Oral & Maxillofacial Pathology, Radiology and Medicine and Associate Dean for Graduate Programs at the NYU College of Dentistry. Chronic neuropathic face is an extremely painful, debilitating disorder affecting approximately three percent of the U.S. population, said Dr. Sirois. It is very often associated with delays in diagnosis and inappropriate treatments that add to patient suffering. The May 10th conference was dedicated to improving patients’ and doctors’ awareness and education regarding the spectrum of neuropathic face pains, and the most advanced concepts of causes, diagnosis, and treatment options.
The conference cosponsors also included Winthrop University Hospital and the Trigeminal Neuralgia Association (TNA), a national, nonprofit association dedicated to the plight of those who suffer from trigeminal neuralgia (TN) and other neuropathic facial pain.